PHGDH and central nervous system cancer: Kaplan–Meier curves indicated that in WHO grade I and II glioma patients, the 5-year survival was 82.3 % in the low-PHGDH expression group compared with 64.5 % in the high-PHGDH expression group (p < 0.001).